Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2536 to 2550 of 9088 results

  1. Ianalumab for treating active Sjogren's disease ID6634

    In development Reference number: GID-TA11836 Expected publication date: TBC

  2. Surovatamig for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more lines of treatment [ID6631]

    Awaiting development Reference number: GID-TA11849 Expected publication date: TBC

  3. Leriglitazone for treating cerebral adrenoleukodystrophy in people 2 years and over [ID3903]

    In development Reference number: GID-HST10069 Expected publication date:  11 April 2027

  4. Surovatamig for treating relapsed or refractory B-cell acute lymphoblastic leukaemia after 2 or more lines of treatment in people 12 years and over [ID6630]

    Awaiting development Reference number: GID-TA11837 Expected publication date: TBC

  5. Deucravacitinib for treating active Sjogren's disease [ID6715]

    Awaiting development Reference number: GID-TA11939 Expected publication date: TBC

  6. Medicines for treating osteoporosis and reducing the risk of fragility fractures (review of TA160, TA161, TA204, TA464, TA791, TA991) [ID6689]

    Awaiting development Reference number: GID-TA11907 Expected publication date:  10 June 2027

  7. Transnasal Panendoscopy

    Topic prioritisation

  8. External stimulation of the auricular branch of the vagus nerve

    Topic prioritisation

  9. Advanced Pelvic Exenteration surgery for complex pelvic cancers

    Topic prioritisation

  10. Lonafarnib for treating progeria and progeroid laminopathies [ID3867]

    Topic prioritisation

  11. Percutaneous transluminal radiofrequency sympathetic denervation of the renal artery for glycemic control

    Topic prioritisation

  12. Phalloplasty

    Topic prioritisation

  13. Seminal Vesicle Lavage

    Topic prioritisation

  14. High Definition – transcranial Electrical Stimulation (HD-tES) for fibromyalgia

    Topic prioritisation

  15. Helium plasma coagulation for treating Respiratory Papillomatosis

    Topic prioritisation